EUVIMEDEUVIMED entdecken
Vergleichsstudie

Global, regional, and national high LDL-cholesterol-related disease burden: an updated analysis of the global burden of disease study 2021

Zechao Xu, Hongmei Yang, Qingliang Wang, Haiying Chen, Chang Ma, Yifei Gao, Huiyi Li, Xueyao Zhang

Nutrition, Metabolism and Cardiovascular Diseases · 2026-12 · 36 (12) · 104861

DOI: 10.1016/j.numecd.2026.104861 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Nutrition, Metabolism and Cardiovascular Diseases, 2026-12. Verfasst von Zechao Xu und 7 weiteren Autor:innen. Beteiligte Einrichtung: University of Chinese Academy of Sciences, No 19 Yuquan Road, Shijingshan District, Beijing, 100049, China. Electronic address: xuzechao@sia.cn. Hauptthemen laut MEDLINE: Cholesterol, LDL, Global Health, Hypercholesterolemia, Cardiovascular Diseases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 36 Literaturangaben. Gefördert von: Doctoral Scientific Research Start-up Project of Liaoning Provincial Natural Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND AND AIMS: High low-density lipoprotein cholesterol (HLDL-C) levels are independently associated with adverse cardiovascular events. Based on the latest Global Burden of Disease Study 2021 (GBD2021) data, we explored the current global, regional, and national HLDL-C-related disease burden under the updated diagnostic criteria. METHODS AND RESULTS: Using data from the GBD2021, we analysed the HLDL-C-related mortality and disability-adjusted life year (DALY) rates between 1990 and 2021, stratified by region, sex, age, and temporal changes. The overall global HLDL-C-related mortality and DALY rates are declining, with a greater burden in men than in women. Nevertheless, the absolute death and DALY numbers have steadily increased by 48·69% and 45·72%, respectively. Only regions with a high sociodemographic index (SDI) achieved a reduction in disease burden. In 2021, middle-SDI regions had the highest death and DALY numbers and the greatest percentage change in these numbers. The highest mortality and DALY rates were found in the middle-high- and low-high-SDI regions, respectively. Globally, China had the heaviest burden and Nauru the highest mortality and DALY rates. Additionally, the proportion of deaths or DALYs from different causes varied with age, with those of ischemic stroke increasing with age. The peak age of HLDL-C-related burden was subtly different between the sexes. CONCLUSION: In most regions, HLDL-C levels are not effectively controlled, resulting in a significant increase in the overall global burden. Targeted measures to prevent HLDL-C-related diseases and reduce disparities across different populations are urgently needed.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cholesterol, LDLGlobal HealthHypercholesterolemiaCardiovascular DiseasesHumansMaleFemaleBiomarkersTime FactorsDisability-Adjusted Life YearsAgedMiddle AgedRisk AssessmentGlobal Burden of DiseasePrognosisAdultRisk FactorsUp-RegulationAged, 80 and over

Stichwörter der Autor:innen

CholesterolDisability-adjusted life yearsGlobal burden of diseaseHypercholesterolemiaLDLMortality

Substanzen

BiomarkersCholesterol, LDL

Autor:innen und Institutionen

  • University of Chinese Academy of Sciences, No 19 Yuquan Road, Shijingshan District, Beijing, 100049, China. Electronic address: xuzechao@sia.cn.
  • Department of Cardiology, The First Hospital of China Medical University, No 155 Nanjing North Street, Heping District, Shenyang, 110001, China. Electronic address: eileen8222@163.com.
  • Department of Hepatobiliary-Pancreatic-Splenic Surgery, The Third Affiliated Hospital, Sun Yat-sen University, No 2693 Kai chuang Avenue, Huangpu District, Guangzhou, 510530, China. Electronic address: wangql5@mail.sysu…
  • Department of Obstetrics, The First Hospital of China Medical University, No 155 Nanjing North Street, Heping District, Shenyang, 110001, China. Electronic address: chhyrabbit@126.com.
  • Department of Cardiology, The First Hospital of China Medical University, No 155 Nanjing North Street, Heping District, Shenyang, 110001, China. Electronic address: machang@cmu.edu.cn.
  • Department of Cardiology, The First Hospital of China Medical University, No 155 Nanjing North Street, Heping District, Shenyang, 110001, China. Electronic address: gaoyifei@cmu.edu.cn.

Förderung

  • Doctoral Scientific Research Start-up Project of Liaoning Provincial Natural Science Foundation

Zitieren

APA

Xu, Z., Yang, H., Wang, Q., Chen, H., Ma, C., Gao, Y., Li, H., & Zhang, X. (2026). Global, regional, and national high LDL-cholesterol-related disease burden: an updated analysis of the global burden of disease study 2021. Nutrition, Metabolism and Cardiovascular Diseases, 36(12), 104861. https://doi.org/10.1016/j.numecd.2026.104861

Vancouver

Xu Z, Yang H, Wang Q, Chen H, Ma C, Gao Y, et al. Global, regional, and national high LDL-cholesterol-related disease burden: an updated analysis of the global burden of disease study 2021. Nutrition, Metabolism and Cardiovascular Diseases. 2026;36(12):104861. doi:10.1016/j.numecd.2026.104861

BibTeX
@article{Xu2026,
  author = {Xu, Zechao and Yang, Hongmei and Wang, Qingliang and Chen, Haiying and Ma, Chang and Gao, Yifei and Li, Huiyi and Zhang, Xueyao},
  title = {Global, regional, and national high LDL-cholesterol-related disease burden: an updated analysis of the global burden of disease study 2021},
  journal = {Nutrition, Metabolism and Cardiovascular Diseases},
  year = {2026},
  volume = {36},
  number = {12},
  pages = {104861},
  doi = {10.1016/j.numecd.2026.104861}
}
Kostenlos starten →